Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

drug development

  • The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
    You have access
    The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
    Xiangxi Meng, Xiangxing Kong, Lei Xia, Runze Wu, Hua Zhu and Zhi Yang
    Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 46S-53S; DOI: https://doi.org/10.2967/jnumed.123.266978
  • You have access
    Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders
    John P. Seibyl
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 12-19; DOI: https://doi.org/10.2967/jnumed.122.264773
  • You have access
    Molecular Imaging in Cancer Drug Development
    Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045
  • You have access
    Identification of Ligands and Translation to Clinical Applications
    Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
  • You have access
    The Use of Microdosing in the Development of Small Organic and Protein Therapeutics
    Mats Bergstrom
    Journal of Nuclear Medicine August 1, 2017, 58 (8) 1188-1195; DOI: https://doi.org/10.2967/jnumed.116.188037
  • You have access
    Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats
    Tal Burt, Douglas C. Rouse, Kihak Lee, Huali Wu, Anita T. Layton, Thomas C. Hawk, Douglas H. Weitzel, Bennett B. Chin, Michael Cohen-Wolkowiez, Shein-Chung Chow and Robert J. Noveck
    Journal of Nuclear Medicine November 1, 2015, 56 (11) 1793-1799; DOI: https://doi.org/10.2967/jnumed.115.160986
SNMMI

© 2025 SNMMI

Powered by HighWire